Wegovy users have fewer kidney-related health problems, according to Reuters analysis of the Novo studyMay 29, 20240 By Maggie Fick LONDON (Reuters) – Novo Nordisk’s (NYSE:) Wegovy anti-obesity drug reduced adverse kidney-related events by 22% in overweight…